Earnings History Data for Myovant Sciences Ltd. (MYOV) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Myovant Sciences Ltd.

Myovant Sciences Ltd. is a biopharmaceutical company. It focused on developing and commercializing therapies for women's health diseases and other endocrine-related disorders, including advanced prostate cancer. The company's product candidate consists of relugolix which are in clinical trial, an oral once-daily small molecule that acts as a gonadotropin-releasing hormone receptor antagonist. Myovant Sciences Ltd. is based in Hamilton, Bermuda.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
27-07-2022	AH	4:05 PM ET (Jul 27)	MYOV	Myovant Sciences Ltd.	1,110	-0.22	-0.13	-0.67	Myovant Sciences GAAP EPS of -$0.22 beats by $0.10, revenue of $116.49M beats by $25.19M [7/27/2022 4:07 PM]	13.20	0.97 (7.93%)	13.00	0.77 (6.30%)	7.67 - 27.43	919,466	590,000	2,570
Myovant Sciences GAAP EPS of -$0.22 beats by $0.10, revenue of $116.49M beats by $25.19M [7/27/2022 4:07 PM] Myovant stock gains ~6% after hours on Q1 revenue jump [7/27/2022 6:26 PM] Myovant Sciences Ltd. (MYOV) Q1 2022 Earnings Call Transcript [Jul-27-22 10:30PM] Myovant Sciences (MYOV) Reports Q1 Loss, Tops Revenue Estimates [Jul-27-22 05:55PM] Myovant Sciences Announces Corporate Updates and Financial Results for First Fiscal Quarter 2022 [Jul-27-22 04:05PM]
10-05-2022	PM	6:55 AM ET (May 10)	MYOV	Myovant Sciences Ltd.	815.09	-0.63	-0.55	-0.89	Myovant Sciences GAAP EPS of -$0.63 misses by $0.09, revenue of $57.6M misses by $14.74M [5/10/2022 7:01 AM]	9.82	2.04 (26.22%)	8.00	0.22 (2.83%)	7.67 - 27.43	2,067,789	766,453	21,850
Myovant Sciences FQ4 2022 Earnings Preview [5/9/2022 12:28 PM] Myovant in pact with Accord Healthcare to commercialize Orgovyx in Europe [5/9/2022 6:48 AM] Myovant Sciences GAAP EPS of -$0.63 misses by $0.09, revenue of $57.6M misses by $14.74M [5/10/2022 7:01 AM] Myovant stock rises 25% as Q4 revenue soars Y/Y, partner Pfizer to buy Biohaven [5/10/2022 2:08 PM] Myovant, Accord Healthcare Ink Relugolix Distribution Pact For Europe In Prostate Cancer [May-09-22 08:54AM] Myovant Sciences and Accord Healthcare, Ltd. Enter into Exclusive License Agreement to Commercialize ORGOVYX® for Advanced Hormone-Sensitive Prostate Cancer in Europe [May-09-22 06:30AM] Myovant Sciences Announces Corporate Updates and Financial Results for Fourth Fiscal Quarter and Fiscal Year Ended March 31, 2022 [May-10-22 06:55AM] Phathom Pharmaceuticals Reports First Quarter 2022 Results and Provides Recent Clinical, Regulatory, and Business Updates [May-10-22 08:00AM] Myovant Sciences (MYOV) Reports Q4 Loss, Misses Revenue Estimates [May-10-22 08:05AM]
26-01-2022	PM	6:55 AM ET (Jan 26)	MYOV	Myovant Sciences Ltd.	1,230	-0.68	-0.59	-0.82	Myovant Sciences GAAP EPS of -$0.68 misses by $0.07, revenue of $54.4M in-line [1/26/2022 6:56 AM]	13.10	0.0 (0.00%)	13.13	0.03 (0.23%)	12.33 - 27.43	858,740	960,000	1,861
Myovant Sciences Q3 2021 Earnings Preview [1/25/2022 11:32 AM] Myovant Sciences GAAP EPS of -$0.68 misses by $0.07, revenue of $54.4M in-line [1/26/2022 6:56 AM] Myovant Sciences Announces Financial Results for Third Quarter of Fiscal Year 2021 and Corporate Updates [Jan-26-22 06:55AM] Enzyvant Appoints Johanna Rossell as Chief Commercial Officer [Jan-26-22 08:00AM] Myovant Sciences (MYOV) Reports Q3 Loss, Misses Revenue Estimates [Jan-26-22 08:15AM] Myovant Sciences Ltd. (MYOV) Q3 2021 Earnings Call Transcript [Jan-26-22 02:00PM]
26-10-2021	PM	6:55 AM ET (Oct 26)	MYOV	Myovant Sciences Ltd.	1,910	-0.23	-0.34	-0.75	Myovant Sciences EPS beats by $0.15, beats on revenue [10/26/2021 7:01 AM]	19.88	-1.55 (-7.23%)	19.74	-1.69 (-7.89%)	13.59 - 30.90	1,800,357	420,000	95,026
Myovant Sciences FQ2 2022 Earnings Preview [10/25/2021 12:45 PM] Myovant Sciences EPS beats by $0.15, beats on revenue [10/26/2021 7:01 AM] Myovant Sciences nears a three-month low after setback for partnership with Pfizer [10/26/2021 11:36 AM] Myovant Sciences Announces Financial Results for Second Quarter of Fiscal Year 2021 and Corporate Updates [Oct-26-21 06:55AM] Myovant Sciences (MYOV) Reports Q2 Loss, Tops Revenue Estimates [Oct-26-21 08:05AM] Why Did Myovant Sciences Shares Fall Despite Q2 Earnings Beat? [Oct-26-21 05:32PM]
28-07-2021	PM	7:00 AM ET (Jul 28)	MYOV	Myovant Sciences Ltd.	1,880	-0.67	-0.21	-0.37	Myovant Sciences EPS misses by $0.36, misses on revenue [7/28/2021 7:00 AM]	19.10	-1.18 (-5.82%)	19.01	-1.27 (-6.26%)	13.42 - 30.90	3,324,674	760,000	2,545
Myovant Sciences EPS misses by $0.36, misses on revenue [7/28/2021 7:00 AM] Infinity Pharmaceuticals, Grove leads healthcare gainers; Dyadic, EyeGate Pharmaceuticals among major losers [7/28/2021 11:01 AM] Myovant Sciences shares fall after Q1 earnings miss [7/28/2021 11:23 AM] Myovant Sciences Announces Financial Results for First Quarter of Fiscal Year 2021 and Corporate Updates [Jul-28-21 06:55AM] Myovant Sciences (MYOV) Reports Q1 Loss, Misses Revenue Estimates [Jul-28-21 08:25AM] Here's Why Myovant Sciences Stock Is Falling Today [Jul-28-21 02:47PM] Myovant Sciences Ltd. (MYOV) Q1 2021 Earnings Call Transcript [Jul-28-21 07:33PM]
11-05-2021	PM	6:55 AM ET (May 11)	MYOV	Myovant Sciences Ltd.	1,720	-0.89	-0.99	-0.73	Myovant Sciences EPS beats by $0.11, misses on revenue [5/11/2021 6:59 AM]	19.76	1.42 (7.74%)	17.65	-0.69 (-3.76%)	11.55 - 30.90	1,147,130	540,000	2,104
Myovant Sciences EPS beats by $0.11, misses on revenue [5/11/2021 6:59 AM] Drug/Biotech Stock Q1 Earnings on May 10: CPRX, PRTA & More [May-10-21 10:40AM] Myovant Sciences Ltd. to Host Earnings Call [May-11-21 06:30AM] Myovant Sciences Announces Corporate Updates and Financial Results for Fourth Fiscal Quarter and Fiscal Year Ended March 31, 2021 [May-11-21 06:58AM] Myovant Sciences (MYOV) Reports Q4 Loss, Tops Revenue Estimates [May-11-21 08:15AM] Myovant Sciences Ltd. (MYOV) Q4 2020 Earnings Call Transcript [May-11-21 08:00PM]
11-02-2021	PM	7:00 AM ET (Feb 11)	MYOV	Myovant Sciences Ltd.	2,200	-0.82	-0.89	-0.96	Myovant Sciences EPS beats by $0.03, misses on revenue [2/11/2021 7:03 AM]	21.99	-1.36 (-5.82%)	23.35	0.0 (0.00%)	5.98 - 30.90	1,373,399	771,264	11,040
Myovant Sciences EPS beats by $0.03, misses on revenue [2/11/2021 7:03 AM] Myovant Sciences: Q3 Earnings Insights [Feb-11-21 09:53AM] Myovant Sciences Announces Corporate Updates and Financial Results for Third Quarter of Fiscal Year 2020 [Feb-11-21 06:55AM]
12-11-2020	PM	8:30 AM ET (Nov 12)	MYOV	Myovant Sciences Ltd.	1,420	-0.75	-0.78	-0.79	Myovant Sciences EPS misses by $0.01 [11/12/2020 7:04 AM]	17.11	0.52 (3.13%)	16.38	-0.21 (-1.27%)	5.39 - 23.04	971,389	604,551	1,692